Skip to main content

Aclaris Therapeutics Soars After Promising Study Against Rheumatoid Arthritis

During the trading day yesterday, Aclaris Therapeutics’ stock shot upwards with a rise of more than 200%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.